StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.29+0.12 (+1.94%)

Close on Nov 17, 2026Market cap $843.31MP/E –Yield –

Immatics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Immatics's price to book ratio was 1.1× on Jan 31, 2025, against 3.7× a year earlier. Over the last 3 years it ranged from 1.1× to 10.7×, with a median of 3.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20251.1×−0.3
2024Dec 31, 20241.5×−2.2
2023Jul 31, 20233.7×−4.1
2022Jan 31, 20227.8×−2.5
2021Dec 31, 202110.2×–

More Immatics figures

See a number that looks wrong?